Please use this identifier to cite or link to this item:
|Title:||In Vivo Absorption of Didanosine Formulated in Pellets Composed of Chitosan Microspheres|
Silva, Classius Ferreira da [UNIFESP]
Dalla Costa, Teresa Cristina T.
Silva, Heloisa [UNIFESP]
Chaud, Marco V.
Santana, Maria Helena A.
Souto, Eliana B.
Universidade Estadual de Campinas (UNICAMP)
Inst Technol & Res
Universidade Federal de São Paulo (UNIFESP)
Univ Rio Grande Sul
Universidade Federal da Bahia (UFBA)
Univ Coimbra FFUC
male adult dogs
|Publisher:||Int Inst Anticancer Research|
|Citation:||In Vivo. Athens: Int Inst Anticancer Research, v. 28, n. 6, p. 1045-1050, 2014.|
|Abstract:||The in vivo absorption of didanosine was studied, focusing on the performance of a novel pharmaceutical formulation for didanosine, composed of chitosan granules containing didanosine incorporated in chitosan microspheres. This novel formulation is aimed at oral administration in AIDS therapy. The experimental results in male adult dogs showed controlled delivery of didanosine along 36 h, with a 2-fold increase in the absorption time of didanosine compared to the commercial granules, gastro-resistant didanosine and tablets. The higher absorption is due to adhesion to the intestinal membrane, improving absorption through increase of residence time, permeation and release. Furthermore, the novel formulation facilitates handling and deglutition, especially in the elderly and children, as well as enhances the taste and reduces the frequency of doses and collateral effects associated with a high concentration of the buffer agents usually used in other formulations.|
|Appears in Collections:||Artigo|
Files in This Item:
There are no files associated with this item.
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.